MPs questions experts on AI in drug discovery and medical research
The use of AI in drug discovery and medical research is the focus of the third session of the Commons Science and Technology Committee’s inquiry into the governance of artificial intelligence (AI).
The Financial Times reported last June that using AI for drug discovery was a “budding industry” with several large pharmaceutical firms investing in start-ups in this area, including Exscientia who MPs will hear from.
The session explores how UK firms are using AI for these purposes, how the technology might develop in the future, and their views on the UK regulatory landscape.
MPs will also explore the wider context behind AI’s increasing use in medical research, hearing from scientist and doctor Professor Fernandez-Reyes, researching how to harness AI to assist with healthcare in low-to-middle-income countries as well as Professor van der Shcaar, involved in the 2019 Topol Review which made recommendations to the NHS on AI.